Christine is a health policy expert with over a decade of experience delivering impactful initiatives across global and European markets. She specialises in building multidisciplinary, multifunded platforms that drive long-term, evidence-based policy change and improve outcomes for patients. She works with leading pharmaceutical companies and NGOs to shape healthcare agendas and deliver high-profile campaigns that influence policy at the highest levels.
Christine leads the oncology programme within the MHP Health team, working across a range of cancers, including prostate, bladder, gynaecological, and haematological cancers. She also works on programmes addressing sickle cell disease and has previously led initiatives on many rare diseases and Alzheimer’s disease.
Christine was previously Director of Partnerships and Development at the Health Policy Partnership, where she led large-scale, multi-stakeholder initiatives across oncology, neurology, cardiovascular disease, and rare diseases. With a BSc in Biochemistry from the University of St Andrews and an MSc in Global Health and Development from UCL, she combines scientific expertise with a passion for creating solutions that address complex healthcare challenges and advance health equity.
[email protected]